Secretome-based acellular therapy of bone marrow-derived mesenchymal stem cells in degenerative and immunological disorders: A narrative review

The bone marrow (BM) plays a pivotal role in homeostasis by supporting hematopoiesis and immune cells' activation, maturation, interaction, and deployment. “BMSC-derived secretome” refers to the complete repertoire of secreted molecules, including nucleic acids, chemokines, growth factors, cyto...

全面介绍

书目详细资料
发表在:Heliyon
Main Authors: Fatema Tuz Zohora, Mansur Aliyu, Ali Akbar Saboor-Yaraghi
格式: 文件
语言:英语
出版: Elsevier 2023-07-01
主题:
在线阅读:http://www.sciencedirect.com/science/article/pii/S2405844023053288
_version_ 1852700122163445760
author Fatema Tuz Zohora
Mansur Aliyu
Ali Akbar Saboor-Yaraghi
author_facet Fatema Tuz Zohora
Mansur Aliyu
Ali Akbar Saboor-Yaraghi
author_sort Fatema Tuz Zohora
collection DOAJ
container_title Heliyon
description The bone marrow (BM) plays a pivotal role in homeostasis by supporting hematopoiesis and immune cells' activation, maturation, interaction, and deployment. “BMSC-derived secretome” refers to the complete repertoire of secreted molecules, including nucleic acids, chemokines, growth factors, cytokines, and lipids from BM-derived mesenchymal stem cells (BMSCs). BMSC-derived secretomes are the current molecular platform for acellular therapy. Secretomes are highly manipulable and can be synthesised in vast quantities using commercially accessible cell lines in the laboratory. Secretomes are less likely to elicit an immunological response because they contain fewer surface proteins. Moreover, the delivery of BMSC-derived secretomes has been shown in numerous studies to be an effective, cell-free therapy method for alleviating the symptoms of inflammatory and degenerative diseases. As a result, secretome delivery from BMSCs has the same therapeutic effects as BMSCs transplantation but may have fewer adverse effects. Additionally, BMSCs’ secretome has therapeutic promise for organoids and parabiosis studies. This review focuses on recent advances in secretome-based cell-free therapy, including its manipulation, isolation, characterisation, and delivery systems. The diverse bioactive molecules of secretomes that successfully treat inflammatory and degenerative diseases of the musculoskeletal, cardiovascular, nervous, respiratory, reproductive, gastrointestinal, and anti-ageing systems were also examined in this review. However, secretome-based therapy has some unfavourable side effects that may restrict its uses. Some of the adverse effects of this modal therapy were briefly mentioned in this review.
format Article
id doaj-art-e547cfca5a0c4a7ea867129e8a980d16
institution Directory of Open Access Journals
issn 2405-8440
language English
publishDate 2023-07-01
publisher Elsevier
record_format Article
spelling doaj-art-e547cfca5a0c4a7ea867129e8a980d162025-08-19T21:20:44ZengElsevierHeliyon2405-84402023-07-0197e1812010.1016/j.heliyon.2023.e18120Secretome-based acellular therapy of bone marrow-derived mesenchymal stem cells in degenerative and immunological disorders: A narrative reviewFatema Tuz Zohora0Mansur Aliyu1Ali Akbar Saboor-Yaraghi2Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, MalaysiaDepartment of Immunology, School of Public Health, Tehran University of Medical Sciences, International Campus, TUMS-IC, Tehran, Iran; Department of Medical Microbiology, Faculty of Clinical Science, College of Health Sciences, Bayero University, Kano, NigeriaDepartment of Immunology, School of Public Health, Tehran University of Medical Sciences, International Campus, TUMS-IC, Tehran, Iran; Corresponding author.The bone marrow (BM) plays a pivotal role in homeostasis by supporting hematopoiesis and immune cells' activation, maturation, interaction, and deployment. “BMSC-derived secretome” refers to the complete repertoire of secreted molecules, including nucleic acids, chemokines, growth factors, cytokines, and lipids from BM-derived mesenchymal stem cells (BMSCs). BMSC-derived secretomes are the current molecular platform for acellular therapy. Secretomes are highly manipulable and can be synthesised in vast quantities using commercially accessible cell lines in the laboratory. Secretomes are less likely to elicit an immunological response because they contain fewer surface proteins. Moreover, the delivery of BMSC-derived secretomes has been shown in numerous studies to be an effective, cell-free therapy method for alleviating the symptoms of inflammatory and degenerative diseases. As a result, secretome delivery from BMSCs has the same therapeutic effects as BMSCs transplantation but may have fewer adverse effects. Additionally, BMSCs’ secretome has therapeutic promise for organoids and parabiosis studies. This review focuses on recent advances in secretome-based cell-free therapy, including its manipulation, isolation, characterisation, and delivery systems. The diverse bioactive molecules of secretomes that successfully treat inflammatory and degenerative diseases of the musculoskeletal, cardiovascular, nervous, respiratory, reproductive, gastrointestinal, and anti-ageing systems were also examined in this review. However, secretome-based therapy has some unfavourable side effects that may restrict its uses. Some of the adverse effects of this modal therapy were briefly mentioned in this review.http://www.sciencedirect.com/science/article/pii/S2405844023053288Bone marrowMesenchymal stem cellsSecretomesAcellular therapyDegenerative disordersImmunological disorders
spellingShingle Fatema Tuz Zohora
Mansur Aliyu
Ali Akbar Saboor-Yaraghi
Secretome-based acellular therapy of bone marrow-derived mesenchymal stem cells in degenerative and immunological disorders: A narrative review
Bone marrow
Mesenchymal stem cells
Secretomes
Acellular therapy
Degenerative disorders
Immunological disorders
title Secretome-based acellular therapy of bone marrow-derived mesenchymal stem cells in degenerative and immunological disorders: A narrative review
title_full Secretome-based acellular therapy of bone marrow-derived mesenchymal stem cells in degenerative and immunological disorders: A narrative review
title_fullStr Secretome-based acellular therapy of bone marrow-derived mesenchymal stem cells in degenerative and immunological disorders: A narrative review
title_full_unstemmed Secretome-based acellular therapy of bone marrow-derived mesenchymal stem cells in degenerative and immunological disorders: A narrative review
title_short Secretome-based acellular therapy of bone marrow-derived mesenchymal stem cells in degenerative and immunological disorders: A narrative review
title_sort secretome based acellular therapy of bone marrow derived mesenchymal stem cells in degenerative and immunological disorders a narrative review
topic Bone marrow
Mesenchymal stem cells
Secretomes
Acellular therapy
Degenerative disorders
Immunological disorders
url http://www.sciencedirect.com/science/article/pii/S2405844023053288
work_keys_str_mv AT fatematuzzohora secretomebasedacellulartherapyofbonemarrowderivedmesenchymalstemcellsindegenerativeandimmunologicaldisordersanarrativereview
AT mansuraliyu secretomebasedacellulartherapyofbonemarrowderivedmesenchymalstemcellsindegenerativeandimmunologicaldisordersanarrativereview
AT aliakbarsabooryaraghi secretomebasedacellulartherapyofbonemarrowderivedmesenchymalstemcellsindegenerativeandimmunologicaldisordersanarrativereview